Provided by Tiger Trade Technology Pte. Ltd.

SKB BIO

538.000
+5.0000.94%
Volume:561.82K
Turnover:301.87M
Market Cap:128.58B
PE:-278.28
High:545.000
Open:541.500
Low:527.500
Close:533.000
52wk High:581.000
52wk Low:339.600
Shares:239.00M
HK Float Shares:177.00M
Volume Ratio:0.80
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.933
ROE:2.92%
ROA:0.03%
PB:20.65
PE(LYR):-278.28
PS:52.83

Loading ...

Sichuan Kelun Biotech Biopharmaceutical (SEHK:6990) After Profitability And Oncology Progress Looks Undervalued

Simply Wall St.
·
Yesterday

Historic Breakthrough in mRNA Cancer Vaccines: E Fund Biotech ETF (03186) Taps Innovation Opportunities Across Hong Kong and US Markets

Stock News
·
Aug 20

SKB BIO Receives Price Target Increase to HK$642 with Buy Rating Maintained by BOCOM International

Deep News
·
Aug 20

Movement Alert|SKB BIO Rises 4.11% in Regular Trading, Multiple Investment Banks Raise Target Prices Boosting Market Confidence

Market Focus
·
Aug 20

China's Ascentage Pharma H1 Revenue Rises 29% on Lisaftoclax Ramp-up

Reuters
·
Aug 20

Earnings Update: Here's Why Analysts Just Lifted Their Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990) Price Target To HK$612

Simply Wall St.
·
Aug 20

Sino Biopharmaceutical H1 Revenue up 10.6% on Innovative Drug Sales

Reuters
·
Aug 19

BofA Securities Raises SKB BIO Price Target to HK$644.4, Projects Full-Year Profitability

Stock News
·
Aug 19

Movement Alert|SKB BIO Declines 3.04% in Regular Trading, Profit-Taking as Earnings Quality Questioned Over One-Time Items

Market Focus
·
Aug 19

China's GenScript Biotech H1 Revenue Rises on AI Drug Discovery

Reuters
·
Aug 18

Germany's Immatics Q2 Revenue Rises but Misses Estimates

Reuters
·
Aug 18

Sichuan Kelun-Biotech (SEHK:6990) Stock Rebound Meets Profit Quality Questions

Simply Wall St.
·
Aug 18

UBS Lifts SKB BIO Price Target to HK$678 on Strong First-Half Profit Beat

Stock News
·
Aug 18

Switzerland's Basilea H1 Revenue Rises on Cresemba Demand; Ups 2026 Profit Outlook

Reuters
·
Aug 18

Hong Kong Stock Flash | Kelun-Biotech (06990) Surges Over 4% Pre-Noon as Commercial Product Portfolio Scales Up, H1 Product Sales Double Year-on-Year

Stock News
·
Aug 18

Movement Alert|SKB BIO Rises 3.25% in Regular Trading, H1 Swing to Profit with Net Income Reaching 388 Million Yuan

Market Focus
·
Aug 18

Humanoid Robot Output Ramps Up as Oil and Gas 15th Five-Year Plan Takes Shape

Stock News
·
Aug 18

Vaccine Maker Sinovac H1 Revenue Rises on Overseas Growth, Approvals

Reuters
·
Aug 17

SKB Biopharma Turns to H1 Profit

MT Newswires Live
·
Aug 17

SKB BIO (06990) Delivers on Both Performance and Innovation, Marking Its Biopharma Ascent

Stock News
·
Aug 17